Links
News Archive
- December 2011
- September 2011
- April 2011
- October 2010
- June 2010
- May 2010
- April 2010
- January 2010
- November 2009
- October 2009
- September 2009
- July 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- November 2008
- October 2008
- July 2008
- June 2008
- May 2008
News
07 dec 2011
Esoform has been sold to Ecolab
Esoform is a third generation (est. 1921) family owned company active in the study, development, manufacturing and commercialization of disinfectants, infection prevention and personal care solutions. Leading player in Italy in the hospital market but also with presence into pharmacies and mass market. It owns a GMP certified state-of-the-art production plant over an area of 13,000 sqm. Headquartered close to Venice, today Esoform has about 50 employees and generates 10M euro sales.
The shareholders of Esoform asked Arietti & Partners to assist them in the sale of the company to an international industrial player. Arietti & Partners, through a series of rounds of bids, optimized their proceeds and obtained a remarkable multiple from Ecolab.
Ecolab (NYSE:ECL) with sales of $6 billion and more than 26,000 associates, is a global leading player in cleaning, sanitizing, food safety and infection prevention products and services. Ecolab delivers comprehensive programs and services to the foodservice, food and beverage processing, healthcare, and hospitality markets in more than 160 countries. Ecolab with the Esoform transaction shows a continuous appetite for M&A: in fact few days ago Ecolab has completed the multibillion acquisition of Nalco (NYSE:NLC) a US global player with 12,000 employees active in more than 150 countries in the water treatment and process improvement business. Nalco had $4 billion in 2010. With this transaction Ecolab plans to expand its Healthcare Business into Europe. In fact Esoform manufacturing plant is planned to become the production hub for whole Europe and not only.
Arietti & Partners advised Esoform in the exit strategy, conducted the negotiations with the potential buyers throughout the closing of the transaction.
The shareholders have been impressed by the positive outcome of the sale process. Mr. Guarniero (seller) said: “I must say that without the assistance of Arietti & Partners we would not have been able to close this transaction. They have played a key role throughout all phases of the project: from the initial negotiations and decision on the strategy to follow with various potential, international buyers all the way down to drafting the documentation and coordinating the due diligence. We are a typical family company and we had to interface with a 6 Billion $ listed US group: without Arietti & Partners it would have been impossible for us. Now our company steps into the league of big players. I believe that my employees and my three generations old company are now in a safe harbor.”
The shareholders of Esoform asked Arietti & Partners to assist them in the sale of the company to an international industrial player. Arietti & Partners, through a series of rounds of bids, optimized their proceeds and obtained a remarkable multiple from Ecolab.
Ecolab (NYSE:ECL) with sales of $6 billion and more than 26,000 associates, is a global leading player in cleaning, sanitizing, food safety and infection prevention products and services. Ecolab delivers comprehensive programs and services to the foodservice, food and beverage processing, healthcare, and hospitality markets in more than 160 countries. Ecolab with the Esoform transaction shows a continuous appetite for M&A: in fact few days ago Ecolab has completed the multibillion acquisition of Nalco (NYSE:NLC) a US global player with 12,000 employees active in more than 150 countries in the water treatment and process improvement business. Nalco had $4 billion in 2010. With this transaction Ecolab plans to expand its Healthcare Business into Europe. In fact Esoform manufacturing plant is planned to become the production hub for whole Europe and not only.
Arietti & Partners advised Esoform in the exit strategy, conducted the negotiations with the potential buyers throughout the closing of the transaction.
The shareholders have been impressed by the positive outcome of the sale process. Mr. Guarniero (seller) said: “I must say that without the assistance of Arietti & Partners we would not have been able to close this transaction. They have played a key role throughout all phases of the project: from the initial negotiations and decision on the strategy to follow with various potential, international buyers all the way down to drafting the documentation and coordinating the due diligence. We are a typical family company and we had to interface with a 6 Billion $ listed US group: without Arietti & Partners it would have been impossible for us. Now our company steps into the league of big players. I believe that my employees and my three generations old company are now in a safe harbor.”